<?xml version="1.0"?><!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd"><ArticleSet>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25547996</Replaces>
		<ArticleTitle>Atopic dermatitis: professional orientation</ArticleTitle>
		<FirstPage>3</FirstPage>
		<LastPage>6</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Paul</FirstName>
				<LastName>Frimat</LastName>
				<Affiliation>University Hospital of Lille 2,&#x0000A;1 avenue Oscar Lambret,&#x0000A;59037 Lille Cedex, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Wided</FirstName>
				<LastName>Boughattas</LastName>
				<Affiliation>University Hospital of Sousse &#x02013;&#x0000A;University of Central Tunisia</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Doroth&#x000E9;e</FirstName>
				<LastName>Even</LastName>
				<Affiliation>University Hospital of Lille 2,&#x0000A;1 avenue Oscar Lambret,&#x0000A;59037 Lille Cedex, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2480</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2480</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>Atopic dermatitis is often exacerbated by the working environment. In order to reduce the risk of allergy, young people must receive better medical guidance when they choose a career. This is all the more relevant for young atopic patients.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">atopic dermatitis</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">work-related skin disease</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">occupational medicine</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">professional orientation</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">career guidance</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25547642</Replaces>
		<ArticleTitle>Skin sensitisation to fragrance ingredients: is there a role for household cleaning/maintenance products?</ArticleTitle>
		<FirstPage>7</FirstPage>
		<LastPage>13</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">David A</FirstName>
				<LastName>Basketter</LastName>
				<Affiliation>DABMEB Consultancy Ltd,&#x0000A;Sharnbrook,&#x0000A;MK44 1PR,&#x0000A;UK</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Sylvie</FirstName>
				<LastName>Lemoine</LastName>
				<Affiliation>AISE,&#x0000A;Brussels,&#x0000A;Belgium</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">John P</FirstName>
				<LastName>McFadden</LastName>
				<Affiliation>Cutaneous Allergy Unit,&#x0000A;St John&#x00027;s Institute of Dermatology,&#x0000A;St Thomas Hospital,&#x0000A;London,&#x0000A;UK</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2472</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2472</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>The induction of contact allergy to fragrance ingredients and the consequent risk of allergic contact dermatitis (ACD) present a human health concern that cannot be ignored. The problem arises when exposure exceeds safe levels, but the source(s) of exposure which lead to induction often remain unclear. This contrasts with the elicitation of ACD, where the eczema frequently can be traced to specific source(s) of skin exposure. Cosmetic products are often implicated, both for induction and elicitation. However, other products contain fragrance ingredients, including household cleaning products. In this paper, the risk assessment concerning the ability of these products to induce fragrance contact allergy is considered and the clinical evidence for the induction and/or elicitation of ACD is reviewed. It can be concluded that the risk of the induction of fragrance contact allergy from household cleaning products is low. Especially where more potent fragrance allergens are used in higher exposure products, the aggregated exposure from such products can augment the risk for the elicitation of ACD. This supports the need to manage this risk via the provision of information to consumers.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">allergic contact dermatitis</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">contact allergy</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">detergents</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">fragrances</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">household cleaning products</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">quantitative risk assessment</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25515598</Replaces>
		<ArticleTitle>Kindler syndrome with severe mucosal involvement in a large Palestinian pedigree</ArticleTitle>
		<FirstPage>14</FirstPage>
		<LastPage>19</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">May</FirstName>
				<LastName>El Hachem</LastName>
				<Affiliation>Dermatology Unit, Bambino Ges&#x000F9; Children&#x00027;s Hospital, IRCCS, Piazza S. Onofrio, 4; 00165, Rome, Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Andrea</FirstName>
				<LastName>Diociaiuti</LastName>
				<Affiliation>Dermatology Unit, Bambino Ges&#x000F9; Children&#x00027;s Hospital, IRCCS, Piazza S. Onofrio, 4; 00165, Rome, Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Vittoria</FirstName>
				<LastName>Proto</LastName>
				<Affiliation>Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell&#x02019;Immacolata, IDI-IRCCS, Via Monti di Creta, 104; 00167, Rome, Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Paola</FirstName>
				<LastName>Fortugno</LastName>
				<Affiliation>Dermatology Unit, Bambino Ges&#x000F9; Children&#x00027;s Hospital, IRCCS, Piazza S. Onofrio, 4; 00165, Rome, Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Giovanna</FirstName>
				<LastName>Zambruno</LastName>
				<Affiliation>Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell&#x02019;Immacolata, IDI-IRCCS, Via Monti di Creta, 104; 00167, Rome, Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Daniele</FirstName>
				<LastName>Castiglia</LastName>
				<Affiliation>Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell&#x02019;Immacolata, IDI-IRCCS, Via Monti di Creta, 104; 00167, Rome, Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Majdy</FirstName>
				<LastName>Naim</LastName>
				<Affiliation>Dermatology Section, Shifa Hospital, Shifa Street, Gaza, Gaza Strip</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2457</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2457</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>Background: Kindler syndrome (KS) is a rare autosomal recessive disease of skin fragility, photosensitivity and progressive poikiloderma. Mucous membranes may also be involved. KS is caused by mutations in the FERMT1 gene encoding kindlin-1. Objectives: We report the clinical and molecular features of the largest kindred with KS to date, comprising 18 affected family members (age range: 12-63 years) from the Gaza Strip. Materials and methods: All the affected family members were clinically examined. In addition a skin biopsy for immunofluorescence testing was obtained from the index case. Molecular analysis of the FERMT1 gene was performed on genomic DNA extracted from peripheral blood of 5 patients. Results: All patients presented skin and eye photosensitivity, cutaneous atrophy, dyschromia and poikiloderma, oral cavity involvement, dysphagia and constipation with anal fissures. In addition, nail dystrophy and digit webbing were observed in most of them. Ocular manifestations detected in all patients comprised ectropion and keratoconjunctivitis, with early development of symblepharon in 17 out of 18 cases and blindness in one. Of note, 17 out of 18 affected family members also suffered from urethral strictures since childhood. Diagnosis was supported by immunofluorescence findings and definitely confirmed by FERMT1 sequencing which identified the homozygous frame-shift mutation c.137_140delTAGT. Conclusions: The high rate of mucosal involvement, its early onset and progressive course are noticeable features of our kindred. Also noteworthy is the lack of muco-cutaneous malignancies, despite the sunny habitat.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">Kindler syndrome</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">symblepharon</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">blindness</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">oral involvement</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">dysphagia</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">anal and urethral strictures</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25847841</Replaces>
		<ArticleTitle>Osteopontin expression in biopsies of calciphylaxis</ArticleTitle>
		<FirstPage>20</FirstPage>
		<LastPage>25</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Cynthia M.</FirstName>
				<LastName>Magro</LastName>
				<Affiliation>Department of Pathology, Laboratory Medicine, Weill Cornell Medical College of Cornell University, 1300 York Ave, New York, NY, 10065 USA</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Shabnam</FirstName>
				<LastName>Momtahen</LastName>
				<Affiliation>Department of Pathology, Laboratory Medicine, Weill Cornell Medical College of Cornell University, 1300 York Ave, New York, NY, 10065 USA</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Joshua W.</FirstName>
				<LastName>Hagen</LastName>
				<Affiliation>Department of Dermatology, University of Pittsburgh Medical Center, 200 Lothrop St, Pittsburgh, PA, 15213 USA</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2448</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2448</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>Background: Calciphylaxis combines features of vascular thrombotic occlusion and endoluminal calcification. In this study we examine the expression of osteopontin as a diagnostic marker and its role in lesional pathogenesis. Methods: 25 formalin-fixed, paraffin embedded skin biopsies of 20 females and 5 males (mean age of 60 years) with a diagnosis of calciphylaxis were assessed for osteopontin expression. Results: Lower extremities were the most commonly involved areas; however a truncal and genital distribution was also noted in 3 cases. Renal failure was present in 21 of 25 cases. One patient had myeloproliferative disorder and one patient had advanced colon cancer. The dominant pathology was localized to the subcutaneous fat, characterized by mural calcification and luminal thrombosis affecting capillaries, venules, arterioles and small arteries. In 2 cases, a subcutaneous thrombogenic vasculopathy without calcification was noted. Osteopontin expression was confined to the subcutis, being most striking in calcified vessels but also apparent in vessels without calcification, including mineral poor variants of calciphylaxis. Conclusion: Calciphylaxis represents a unique calcific thrombogenic vasculopathy, not limited to renal failure. Ectopic osteopontin expression may define a critical and initial event in the calciphylaxis pathogenesis. Therapeutic agents designed to reduce osteopontin expression may be of value in its treatment.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">calciphylaxis</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">endoluminal calcification</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">osteopontin expression</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">thrombogenic vasculopathy</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25514750</Replaces>
		<ArticleTitle>Systemic inflammatory response and calcification markers in patients with long lasting moderate-severe chronic spontaneous urticaria</ArticleTitle>
		<FirstPage>26</FirstPage>
		<LastPage>28</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Alicja</FirstName>
				<LastName>Grzanka</LastName>
				<Affiliation>Department of Internal Diseases,&#x0000A;Dermatology and Allergology,&#x0000A;Medical University of Silesia,&#x0000A;Katowice,&#x0000A;ul. M. Curie-Sklodowskiej 10,&#x0000A;41-813 Zabrze,&#x0000A;Poland</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Edyta</FirstName>
				<LastName>Machura</LastName>
				<Affiliation>Pediatric Department,&#x0000A;Medical University of Silesia,&#x0000A;Zabrze,&#x0000A;Poland</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Maciej</FirstName>
				<LastName>Misiolek</LastName>
				<Affiliation>Clinical Department of Otolaryngology in Zabrze, Medical University of Silesia, Katowice, Poland</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Renata</FirstName>
				<LastName>Polaniak</LastName>
				<Affiliation>Department of Human Nutrition,&#x0000A;Faculty of Public Health in Bytom,&#x0000A;Medical University of Silesia,&#x0000A;Katowice,&#x0000A;Poland</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Jacek</FirstName>
				<LastName>Kasperski</LastName>
				<Affiliation>Department of Prosthetic Dentistry in Bytom,&#x0000A;Medical University of Silesia,&#x0000A;Katowice,&#x0000A;Poland</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Alicja</FirstName>
				<LastName>Kasperska-Zajac</LastName>
				<Affiliation>Department of Internal Diseases,&#x0000A;Dermatology and Allergology,&#x0000A;Medical University of Silesia,&#x0000A;Katowice,&#x0000A;ul. M. Curie-Sklodowskiej 10,&#x0000A;41-813 Zabrze,&#x0000A;Poland</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2474</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2474</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>Background: Low grade inflammation is associated with both chronic spontaneous urticaria (CSU) and atherosclerosis. Data regarding an association between urticarial inflammation and atherosclerosis and subsequent cardiovascular events are scarce. It has been demonstrated that matrix GLA protein (MGP), a biomarker of arterial calcification, is increased in patients with atherosclerosis. Objectives: To evaluate circulating levels of markers of arterial calcification and acute phase response (APR) in patients with CSU. Methods: Concentrations of MGP and IL-6 were measured in venous blood samples of patients with long-lasting moderate-severe CSU. Results: There were no significant differences in serum MGP concentration between healthy subjects and CU patients. Serum IL-6 concentration was significantly higher in CSU patients as compared with healthy subjects. Conclusions: The results confirm that CSU is accompanied by a low grade systemic inflammatory state. However, the long lasting urticarial inflammation was not paralleled by an increased circulating level of the calcification marker matrix Gla protein.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">matrix Gla Protein</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">chronic spontaneous urticaria</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">acute phase response</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">calcification</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">chronic inflammation</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25548082</Replaces>
		<ArticleTitle>[<sup>123</sup>I]ICF01012 melanoma imaging and [<sup>131</sup>I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models</ArticleTitle>
		<FirstPage>29</FirstPage>
		<LastPage>35</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Claire</FirstName>
				<LastName>Viallard</LastName>
				<Affiliation>Clermont Universit&#x000E9;, Universit&#x000E9; d&#x02019;Auvergne, Imagerie Mol&#x000E9;culaire et Th&#x000E9;rapie Vectoris&#x000E9;e, BP 10448, Inserm, U 990, F-63000 Clermont-Ferrand, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yann</FirstName>
				<LastName>Perrot</LastName>
				<Affiliation>Clermont Universit&#x000E9;, Universit&#x000E9; Blaise Pascal, CNRS/IN2P3, Laboratoire de Physique Corpusculaire, BP 10448, F-63000 Clermont-Ferrand, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Zied</FirstName>
				<LastName>Boudhraa</LastName>
				<Affiliation>Clermont Universit&#x000E9;, Universit&#x000E9; d&#x02019;Auvergne, Imagerie Mol&#x000E9;culaire et Th&#x000E9;rapie Vectoris&#x000E9;e, BP 10448, Inserm, U 990, F-63000 Clermont-Ferrand, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Elodie</FirstName>
				<LastName>Jouberton</LastName>
				<Affiliation>Centre Jean Perrin, Clermont-Ferrand, F-63011, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Elisabeth</FirstName>
				<LastName>Miot-Noirault</LastName>
				<Affiliation>Clermont Universit&#x000E9;, Universit&#x000E9; d&#x02019;Auvergne, Imagerie Mol&#x000E9;culaire et Th&#x000E9;rapie Vectoris&#x000E9;e, BP 10448, Inserm, U 990, F-63000 Clermont-Ferrand, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Mathilde</FirstName>
				<LastName>Bonnet</LastName>
				<Affiliation>U1071 INSERM Universit&#x000E9; d&#x02019;Auvergne, M2iSH Clermont-Ferrand, F-63000, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Sophie</FirstName>
				<LastName>Besse</LastName>
				<Affiliation>Clermont Universit&#x000E9;, Universit&#x000E9; d&#x02019;Auvergne, Imagerie Mol&#x000E9;culaire et Th&#x000E9;rapie Vectoris&#x000E9;e, BP 10448, Inserm, U 990, F-63000 Clermont-Ferrand, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Florence</FirstName>
				<LastName>Mishellany</LastName>
				<Affiliation>Centre Jean Perrin, Clermont-Ferrand, F-63011, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Anne</FirstName>
				<LastName>Cayre</LastName>
				<Affiliation>Centre Jean Perrin, Clermont-Ferrand, F-63011, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Lydia</FirstName>
				<LastName>Maigne</LastName>
				<Affiliation>Clermont Universit&#x000E9;, Universit&#x000E9; Blaise Pascal, CNRS/IN2P3, Laboratoire de Physique Corpusculaire, BP 10448, F-63000 Clermont-Ferrand, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Latifa</FirstName>
				<LastName>Rbah-Vidal</LastName>
				<Affiliation>Clermont Universit&#x000E9;, Universit&#x000E9; d&#x02019;Auvergne, Imagerie Mol&#x000E9;culaire et Th&#x000E9;rapie Vectoris&#x000E9;e, BP 10448, Inserm, U 990, F-63000 Clermont-Ferrand, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Michel</FirstName>
				<LastName>D&#x02019;Incan</LastName>
				<Affiliation>Clermont Universit&#x000E9;, Universit&#x000E9; d&#x02019;Auvergne, Imagerie Mol&#x000E9;culaire et Th&#x000E9;rapie Vectoris&#x000E9;e, BP 10448, Inserm, U 990, F-63000 Clermont-Ferrand, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Florent</FirstName>
				<LastName>Cachin</LastName>
				<Affiliation>Centre Jean Perrin, Clermont-Ferrand, F-63011, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Jean-Michel</FirstName>
				<LastName>Chezal</LastName>
				<Affiliation>Clermont Universit&#x000E9;, Universit&#x000E9; d&#x02019;Auvergne, Imagerie Mol&#x000E9;culaire et Th&#x000E9;rapie Vectoris&#x000E9;e, BP 10448, Inserm, U 990, F-63000 Clermont-Ferrand, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Fran&#x000E7;oise</FirstName>
				<LastName>Degoul</LastName>
				<Affiliation>Clermont Universit&#x000E9;, Universit&#x000E9; d&#x02019;Auvergne, Imagerie Mol&#x000E9;culaire et Th&#x000E9;rapie Vectoris&#x000E9;e, BP 10448, Inserm, U 990, F-63000 Clermont-Ferrand, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2481</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2481</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>Melanin-targeting radiotracers are interesting tools for imaging and treatment of pigmented melanoma metastases. However, variation of the pigment concentration may alter the efficiency of such targeting. A clear assessment of both tumor melanin status and dosimetry are therefore prerequisites for internal radiotherapy of disseminated melanoma. The melanin tracer ICF01012 was labelled with iodine-123 for melanoma imaging in pigmented murine B16F0 and human SK-Mel 3 melanomas. In vivo imaging showed that the uptake of [<sup>123</sup>I]ICF01012 to melanomas correlated significantly with melanin content. Schedule treatment of 3 &#x000D7; 25 MBq [<sup>131</sup>I]ICF01012 significantly reduced SK-Mel 3 tumor growth and significantly increased the median survival in treated mice. For this protocol, the calculated delivered dose was 53.2&#x000A0;Gy. Radio-iodinated ICF01012 is a good candidate for both imaging and therapeutic purposes for patients with metastatic pigmented melanomas.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">dosimetry</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">imaging</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">melanin</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">melanoma</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">radiotracer</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">targeted radionuclide therapy</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25500362</Replaces>
		<ArticleTitle>Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids</ArticleTitle>
		<FirstPage>36</FirstPage>
		<LastPage>44</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Fran&#x000E7;ois</FirstName>
				<LastName>Chasset</LastName>
				<Affiliation>APHP Department of Dermatology H&#x000F4;pital Saint-Louis,&#x0000A;1, avenue Claude-Vellefaux.&#x0000A;75010 Paris, France;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;INSERM U976</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">C&#x000E9;cile</FirstName>
				<LastName>Pages</LastName>
				<Affiliation>APHP Department of Dermatology H&#x000F4;pital Saint-Louis,&#x0000A;1, avenue Claude-Vellefaux.&#x0000A;75010 Paris, France;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;INSERM U976</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Lucie</FirstName>
				<LastName>Biard</LastName>
				<Affiliation>APHP Department of Biostatistics and Medical Information,&#x0000A;H&#x000F4;pital Saint-Louis;&#x0000A;ECSTRA Team,&#x0000A;CRESS UMR 1153,&#x0000A;INSERM,&#x0000A;Paris Diderot University</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Jennifer</FirstName>
				<LastName>Roux</LastName>
				<Affiliation>APHP Department of Dermatology H&#x000F4;pital Saint-Louis,&#x0000A;1, avenue Claude-Vellefaux.&#x0000A;75010 Paris, France;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;INSERM U976</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Irina</FirstName>
				<LastName>Sidina</LastName>
				<Affiliation>APHP Department of Dermatology H&#x000F4;pital Saint-Louis,&#x0000A;1, avenue Claude-Vellefaux.&#x0000A;75010 Paris, France;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;INSERM U976</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Isabelle</FirstName>
				<LastName>Madelaine</LastName>
				<Affiliation>APHP Department of Pharmacy H&#x000F4;pital Saint-Louis&#x000A0;;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;Paris, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Nicole</FirstName>
				<LastName>Basset-Seguin</LastName>
				<Affiliation>APHP Department of Dermatology H&#x000F4;pital Saint-Louis,&#x0000A;1, avenue Claude-Vellefaux.&#x0000A;75010 Paris, France;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;INSERM U976</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Manuelle</FirstName>
				<LastName>Viguier</LastName>
				<Affiliation>APHP Department of Dermatology H&#x000F4;pital Saint-Louis,&#x0000A;1, avenue Claude-Vellefaux.&#x0000A;75010 Paris, France;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;INSERM U976</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Nika</FirstName>
				<LastName>Madjlessi-EzrA</LastName>
				<Affiliation>APHP Department of Dermatology H&#x000F4;pital Saint-Louis,&#x0000A;1, avenue Claude-Vellefaux.&#x0000A;75010 Paris, France;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;INSERM U976</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Pierre</FirstName>
				<LastName>Schneider</LastName>
				<Affiliation>APHP Department of Dermatology H&#x000F4;pital Saint-Louis,&#x0000A;1, avenue Claude-Vellefaux.&#x0000A;75010 Paris, France;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;INSERM U976</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Martine</FirstName>
				<LastName>Bagot</LastName>
				<Affiliation>APHP Department of Dermatology H&#x000F4;pital Saint-Louis,&#x0000A;1, avenue Claude-Vellefaux.&#x0000A;75010 Paris, France;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;INSERM U976</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Matthieu</FirstName>
				<LastName>Resche-Rigon</LastName>
				<Affiliation>APHP Department of Biostatistics and Medical Information,&#x0000A;H&#x000F4;pital Saint-Louis;&#x0000A;ECSTRA Team,&#x0000A;CRESS UMR 1153,&#x0000A;INSERM,&#x0000A;Paris Diderot University</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">C&#x000E9;leste</FirstName>
				<LastName>Lebbe</LastName>
				<Affiliation>APHP Department of Dermatology H&#x000F4;pital Saint-Louis,&#x0000A;1, avenue Claude-Vellefaux.&#x0000A;75010 Paris, France;&#x0000A;Universit&#x000E9; Paris 7-Diderot,&#x0000A;INSERM U976</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2471</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2471</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>Ipilimumab is an anti-CTLA-4 antibody which has recently been approved in Europe as a monotherapy in the treatment of metastatic melanoma. We report a single-center study among patients treated within a Temporary Authorization for Use (TAU) protocol. We also performed a review of the literature involving expanded access program studies with a focus on factors associated with overall survival (OS). Patients and methods: This retrospective, observational study included patients between June 2010 and July 2011 with a diagnosis of non-resectable stage III or IV melanoma with at least one previous line of chemotherapy. Treatment consisted of four courses of ipilimumab at a dose of 3mg/kg every three weeks. Results: 45 patients were included, among whom 23 (51%) had brain metastases. 33 (71%) of the patients completed the induction phase. The best overall response rate (BORR) was 13% and median overall survival (OS) was 8 months (95%CI: 7 to 12). OS was not different between patients with brain metastases at baseline and those without (p&#x000A0;=&#x000A0;0.10), regardless of BRAF V600E status (p&#x000A0;=&#x000A0;0.61). OS was poorer in patients who were being treated with corticoids at baseline (p&#60;0.001) or with LDH at baseline &#x0003E; 500 UI/ml (p&#x000A0;=&#x000A0;0.008). Conclusion: A subset of patients most likely to benefit from ipilimumab should be defined. In our series we found a negative association of baseline corticosteroids with OS. Unlike high LDH levels, BRAF V600 E status and brain metastases should not be barriers to the initiation of treatment.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">ipilimumab</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">melanoma</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">baseline corticosteroids</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25547029</Replaces>
		<ArticleTitle>Prevalence of common and atypical melanocytic nevi in young adults and its relationship with sun protection and exposure habits</ArticleTitle>
		<FirstPage>45</FirstPage>
		<LastPage>51</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">B&#x000E1;rbara Mariela</FirstName>
				<LastName>Lopez-Ravello</LastName>
				<Affiliation>Dermatology Department,&#x0000A;School of Medicine,&#x0000A;Granada University, Spain</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Salvador</FirstName>
				<LastName>Arias-Santiago</LastName>
				<Affiliation>Dermatology Department,&#x0000A;Virgen de las Nieves University Hospital,&#x0000A;Av Fuerzas Armandas s/n,&#x0000A;Granada 18014, Spain</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Maria Antonia</FirstName>
				<LastName>Fernandez-Pugnaire</LastName>
				<Affiliation>Dermatology Department,&#x0000A;San Cecilio University Hospital,&#x0000A;Granada, Spain</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Salvio Serrano</FirstName>
				<LastName>Ortega</LastName>
				<Affiliation>Dermatology Department,&#x0000A;School of Medicine,&#x0000A;Granada University, Spain</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Agust&#x000ED;n</FirstName>
				<LastName>Buend&#x000ED;a-Eisman</LastName>
				<Affiliation>Dermatology Department,&#x0000A;School of Medicine,&#x0000A;Granada University, Spain</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2482</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2482</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>The incidence of melanoma in young adults is rising. The design of appropriate preventive measures requires the analysis of risk factors, including the prevalence of common and atypical melanocytic nevi (MN) and sun protection and exposure habits. To establish the prevalence and density of common and atypical MN in young adults (18-25 yrs) and their relationship with sun exposure and protection habits. Cross-sectional descriptive study was undertaken in 535 university students from southern Spain to gather data on: the number, density, body localization, and characteristics of common and atypical nevi; phototype; sunburn history; sun protection and exposure habits; and family history of skin cancer. Means of 94.28 common MN and 0.06 atypical MN were detected; most MN were &#x02264;2&#x000A0;mm in diameter; MN were more frequently detected on upper (p&#60;0.01) and lower (p&#60;0.0001 limbs in females versus males and on the trunk (p&#x000A0;=&#x000A0;0.08) in males versus females. Nevus density was higher in females in all body areas. Sunburns (in the previous summer) were reported by 88.2% of participants, while cream with SPF &#x02265;15 was not used by 75.8%. Mean number of atypical MN was higher in those with low phototypes and a family history of skin cancer. Mean number of common MN was elevated and atypical MN were associated with a low phototype and a family history of skin cancer. Sunburn history was significantly associated with younger age and with sun exposure between mid-day and 6 pm.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">nevus</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">melanoma</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">sunburn</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">phototype</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">skin cancer prevention</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">sun exposure</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25333704</Replaces>
		<ArticleTitle>Efficacy and safety of embolization in arteriovenous malformations of the extremities and head and neck: a retrospective study of 32 cases</ArticleTitle>
		<FirstPage>52</FirstPage>
		<LastPage>56</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">&#x000C9;lodie</FirstName>
				<LastName>Le Fourn</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Denis</FirstName>
				<LastName>Herbreteau</LastName>
				<Affiliation>Department of Neuroradiology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Chrysanthi</FirstName>
				<LastName>Papagiannaki</LastName>
				<Affiliation>Department of Neuroradiology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">G&#x000E9;rard</FirstName>
				<LastName>Lorette</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Dominique</FirstName>
				<LastName>Sirinelli</LastName>
				<Affiliation>Department of Paediatric Radiology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Dominique</FirstName>
				<LastName>Goga</LastName>
				<Affiliation>Department of Maxillofacial Surgery,&#x0000A;Hospital Trousseau, CHRU Tours&#x0000A;Avenue de la R&#x000E9;publique,&#x0000A;37044 Tours Cedex 9, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Annabel</FirstName>
				<LastName>Maruani</LastName>
				<Affiliation>Department of Dermatology,, INSERM U930, University Fran&#x000E7;ois Rabelais, Tours, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2450</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2450</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>Background: Definitive treatment of arteriovenous malformations (AVMs) consists of complete surgical excision. When not possible, embolization may be performed. Objectives: We aimed to evaluate the efficacy and safety of embolization for AVMs of the extremities and head and neck. Materials and methods: This retrospective study included all patients undergoing embolization for AVMs of skin and soft tissues on the limbs, head and neck, in the University Hospital Center of Tours between January 1996 and December 2009. The main outcome was efficacy, assessed by two independent assessors, as the percentage of AVM devascularized at the end of embolization. Secondary outcomes were patient satisfaction, evolution of symptoms and safety of embolization. Results: We included 32 AVMs in 31 patients, for 66 embolizations evaluated. In 18 AVMs (56.3%), devascularization was greater than 75% of the initial vascularization. Efficacy was lower for AVMs of the upper limbs than other body parts (p&#x000A0;=&#x000A0;0.003). For 18 patients who could be contacted by telephone, the mean global satisfaction was 6.0&#x000A0;&#x000B1;&#x000A0;2.7 on a scale of 0 to 10, and 13 (72.2%) reported an improvement of the symptoms linked to the AVM. Severe adverse events were reported after 4 embolizations, all located on the head and neck. Conclusion: Embolization can lead to good devascularization and improve symptoms linked to AVMs, especially in lower limbs. Minor complications are frequent, and severe adverse events may occur, especially after procedures on the head and neck.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">Angioma</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">Arteriovenous malformations</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">Embolization</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">Safety</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">Treatment</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">Vascular anomalies</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25333645</Replaces>
		<ArticleTitle>Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool</ArticleTitle>
		<FirstPage>57</FirstPage>
		<LastPage>63</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Jose Luis</FirstName>
				<LastName>L&#x000F3;pez Estebar&#x000E1;nz</LastName>
				<Affiliation>Department of Dermatology, Fundaci&#x000F3;n Hospital Alcorc&#x000F3;n, Madrid, Spain</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Pedro</FirstName>
				<LastName>Zarco-Montejo</LastName>
				<Affiliation>Department of Rheumatology, Fundaci&#x000F3;n Hospital Alcorc&#x000F3;n, Madrid, Spain</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">M Luz</FirstName>
				<LastName>Samaniego</LastName>
				<Affiliation>Statistical Department, Trial Form Support, Madrid, Spain</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Carmen</FirstName>
				<LastName>Garc&#x000ED;a-Calvo</LastName>
				<Affiliation>Medical Department, Pfizer Spain, Avenida de Europa 20B, Parque Empresarial La Moraleja, Alcobendas, Madrid, Spain</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2449</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2449</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>Background: Diagnosing and initiating treatment of psoriatric arthritis (PsA) as early as possible is essential to prevent irreversible joint destruction and poor clinical outcomes. Dermatologists are uniquely placed to identify early symptoms of PsA in psoriasis patients but levels of under- and late-diagnosis remain high. Objective: To evaluate the prevalence and clinical features of PsA in Spanish psoriatic patients attended by dermatologists and then referred to rheumatologic units for PsA diagnosis confirmation. Methods: a multicenter, non-interventional, cross-sectional trial conducted at 40 hospitals in Spain. Patients were initially screened for PsA by a dermatologist based on clinical evaluation and results from the Psoriatic Arthritis Screening and Evaluation (PASE) Questionnaire. All patients were then evaluated by a blinded rheumatologist for the presence of PsA using Moll and Wright criteria and Classification Criteria for Psoriatic Arthritis (CASPAR). Results: Of 375 psoriatic patients enrolled at dermatology units, 28.6% patients scored &#x02265;44 in PASE, whereas 32.3% patients screened positive for suspicion of PsA (clinical evaluation and/or PASE). Correlation of suspicion of PsA by dermatologists and PASE score was 0.368 (Pearson correlation coefficient). Following rheumatologic assessment, prevalence of PsA was 22.9% (86/375 patients) according to Moll and Wright and CASPAR criteria. The correlation of diagnosis of PsA between dermatologists and rheumatologists was 0.410 (Kappa Index). Conclusions: Prevalence of PsA in our study was within the range reported in other studies. Our analyses found only a moderate correlation in the diagnosis of PsA between dermatologists and rheumatologists. The screening questionnaire, PASE, showed a moderate predictive value for the diagnosis of PsA.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">assessment</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">dermatologist</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">diagnosis</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">prevalence</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">psoriasis</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">psoriatic arthritis</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">rheumatologist</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25514606</Replaces>
		<ArticleTitle>Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk</ArticleTitle>
		<FirstPage>64</FirstPage>
		<LastPage>69</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Andrea</FirstName>
				<LastName>Chiricozzi</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;University of Rome Tor Vergata,&#x0000A;Via Montpellier 1,&#x0000A;00133, Rome,&#x0000A;Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Luca</FirstName>
				<LastName>Bianchi</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;University of Rome Tor Vergata,&#x0000A;Via Montpellier 1,&#x0000A;00133, Rome,&#x0000A;Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Arianna</FirstName>
				<LastName>Zangrilli</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;University of Rome Tor Vergata,&#x0000A;Via Montpellier 1,&#x0000A;00133, Rome,&#x0000A;Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Mauro</FirstName>
				<LastName>Bavetta</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;University of Rome Tor Vergata,&#x0000A;Via Montpellier 1,&#x0000A;00133, Rome,&#x0000A;Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Alessandro</FirstName>
				<LastName>Giunta</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;University of Rome Tor Vergata,&#x0000A;Via Montpellier 1,&#x0000A;00133, Rome,&#x0000A;Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Sergio</FirstName>
				<LastName>Chimenti</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;University of Rome Tor Vergata,&#x0000A;Via Montpellier 1,&#x0000A;00133, Rome,&#x0000A;Italy</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Rosita</FirstName>
				<LastName>Saraceno</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;University of Rome Tor Vergata,&#x0000A;Via Montpellier 1,&#x0000A;00133, Rome,&#x0000A;Italy</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2473</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2473</ArticleId></ArticleIdList>
		<History></History>
		<Abstract>Background: Psoriasis is a chronic skin disorder which negatively impacts a patient&#x00027;s quality of life (QoL). A recently published assessment tool, PsoDisk, has been proposed to evaluate patient&#x00027;s QoL. Objective: The aim of this study was to test PsoDisk as a QoL assessment tool in psoriatic patients undergoing treatment with adalimumab. Methods: A retrospective, monocentric study, including patients who completed at least 48 weeks of both adalimumab therapy and PsoDisk assessment. PASI was assessed by the physician whereas the PsoDisk test was self-performed by the patient. Both were evaluated at each control visit throughout the study-period in order to detect changes in disease severity and the impact of quality of life, respectively. Results: In total, we evaluated 31 patients selected from our database. At baseline, all aspects of patients&#x02019; psycho-emotional and social lives were impaired. PASI score reduction correlated with a PsoDisk score decrease (r&#x000A0;=&#x000A0;0.97; p&#x000A0;=&#x000A0;0.02), reflecting an overall improvement of patient&#x00027;s QoL. Conclusion: PsoDisk was found to be easy to administer and intuitive for interpreting clinical results.</Abstract>
		<ObjectList>
			<Object Type="keyword">
				<Param Name="value">psoriasis</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">quality of life</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">biologicals</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">adalimumab</Param>
			</Object>
			<Object Type="keyword">
				<Param Name="value">Psodisk</Param>
			</Object>
		</ObjectList>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25366814</Replaces>
		<ArticleTitle>The different intensity of autoantibody deposits in bullous pemphigoid associated with psoriasis vulgaris</ArticleTitle>
		<FirstPage>70</FirstPage>
		<LastPage>71</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Chihiro</FirstName>
				<LastName>Nakayama</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Hokkaido University Graduate School of Medicine,&#x0000A;North 15 West 7,&#x0000A;Kita-ku, Sapporo 060-8638,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hiroaki</FirstName>
				<LastName>Iwata</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Hokkaido University Graduate School of Medicine,&#x0000A;North 15 West 7,&#x0000A;Kita-ku, Sapporo 060-8638,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Naoya</FirstName>
				<LastName>Haga</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Hokkaido University Graduate School of Medicine,&#x0000A;North 15 West 7,&#x0000A;Kita-ku, Sapporo 060-8638,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yohei</FirstName>
				<LastName>Hamade</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Hokkaido University Graduate School of Medicine,&#x0000A;North 15 West 7,&#x0000A;Kita-ku, Sapporo 060-8638,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Osamu</FirstName>
				<LastName>Mizuno</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Hokkaido University Graduate School of Medicine,&#x0000A;North 15 West 7,&#x0000A;Kita-ku, Sapporo 060-8638,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Wataru</FirstName>
				<LastName>Nishie</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Hokkaido University Graduate School of Medicine,&#x0000A;North 15 West 7,&#x0000A;Kita-ku, Sapporo 060-8638,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hiroshi</FirstName>
				<LastName>Shimizu</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Hokkaido University Graduate School of Medicine,&#x0000A;North 15 West 7,&#x0000A;Kita-ku, Sapporo 060-8638,&#x0000A;Japan</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2444</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2444</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25679339</Replaces>
		<ArticleTitle>Refractory metastasis of cutaneous angiosarcoma showing complete response to pazopanib</ArticleTitle>
		<FirstPage>71</FirstPage>
		<LastPage>73</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Susumu</FirstName>
				<LastName>Fujiwara</LastName>
				<Affiliation>Division of Dermatology,&#x0000A;Department of Internal Related, Kobe University Graduate School of Medicine,&#x0000A; 7-5-1 Kusunoki-cho, &#x0000A;Chuo-ku, Kobe 650-0017, &#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hiroshi</FirstName>
				<LastName>Nagai</LastName>
				<Affiliation>Division of Dermatology,&#x0000A;Department of Internal Related, Kobe University Graduate School of Medicine,&#x0000A; 7-5-1 Kusunoki-cho, &#x0000A;Chuo-ku, Kobe 650-0017, &#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yuji</FirstName>
				<LastName>Nakamachi</LastName>
				<Affiliation>Department of clinical Laboratory,&#x0000A;Kobe University Hospital,&#x0000A;7-5-2 Kusunoki-cho,&#x0000A;Chuo-ku, Kobe 650-0017,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Seiji</FirstName>
				<LastName>Kawano</LastName>
				<Affiliation>Department of clinical Laboratory,&#x0000A;Kobe University Hospital,&#x0000A;7-5-2 Kusunoki-cho,&#x0000A;Chuo-ku, Kobe 650-0017,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Chikako</FirstName>
				<LastName>Nishigori</LastName>
				<Affiliation>Division of Dermatology,&#x0000A;Department of Internal Related, Kobe University Graduate School of Medicine,&#x0000A; 7-5-1 Kusunoki-cho, &#x0000A;Chuo-ku, Kobe 650-0017, &#x0000A;Japan</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2451</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2451</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25513778</Replaces>
		<ArticleTitle>Stoma creation for treatment of primary perianal Paget&#x00027;s disease</ArticleTitle>
		<FirstPage>73</FirstPage>
		<LastPage>74</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Hiroyuki</FirstName>
				<LastName>Goto</LastName>
				<Affiliation>Division of Dermatology,&#x0000A;Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University,, Department of Dermatology,&#x0000A;Shizuoka Cancer Center</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yuichi</FirstName>
				<LastName>Yoshida</LastName>
				<Affiliation>Division of Dermatology,&#x0000A;Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yoshio</FirstName>
				<LastName>Kiyohara</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Shizuoka Cancer Center</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yoshiko</FirstName>
				<LastName>Suyama</LastName>
				<Affiliation>Divison of Plastic Surgery,&#x0000A;Faculty of Medicine,&#x0000A;Tottori University,&#x0000A;86 Nishi-cho, Yonago-shi,&#x0000A;Tottori 683-8503, Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Bin</FirstName>
				<LastName>Nakayama</LastName>
				<Affiliation>Divison of Plastic Surgery,&#x0000A;Faculty of Medicine,&#x0000A;Tottori University,&#x0000A;86 Nishi-cho, Yonago-shi,&#x0000A;Tottori 683-8503, Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Osamu</FirstName>
				<LastName>Yamamoto</LastName>
				<Affiliation>Division of Dermatology,&#x0000A;Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2453</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2453</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25500110</Replaces>
		<ArticleTitle>Metastatic cutaneous Crohn&#x00027;s disease in a child</ArticleTitle>
		<FirstPage>74</FirstPage>
		<LastPage>75</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Young</FirstName>
				<LastName>Her</LastName>
				<Affiliation>Department of Dermatology, Kangwon National University, Chuncheon, Korea</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">So Eun</FirstName>
				<LastName>Park</LastName>
				<Affiliation>Department of Dermatology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 150, Sungan-ro, Gangdong-gu, Seoul 134-701, Korea</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Sang Seok</FirstName>
				<LastName>Kim</LastName>
				<Affiliation>Department of Dermatology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 150, Sungan-ro, Gangdong-gu, Seoul 134-701, Korea</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Chul Woo</FirstName>
				<LastName>Kim</LastName>
				<Affiliation>Department of Dermatology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 150, Sungan-ro, Gangdong-gu, Seoul 134-701, Korea</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2456</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2456</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25499969</Replaces>
		<ArticleTitle>Late presentation of X-linked dyskeratosis congenita with a missense mutation in codon 350 of the dyskerin protein</ArticleTitle>
		<FirstPage>75</FirstPage>
		<LastPage>76</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Naoya</FirstName>
				<LastName>Mori</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Teruhiko</FirstName>
				<LastName>Makino</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Megumi</FirstName>
				<LastName>Mizawa</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Ko</FirstName>
				<LastName>Kagoyama</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hirokazu</FirstName>
				<LastName>Kanegane</LastName>
				<Affiliation>Department of Pediatrics</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hirotoshi</FirstName>
				<LastName>Sakaguchi</LastName>
				<Affiliation>Department of Hematology and Oncology,&#x0000A;Children&#x00027;s Medical Center,&#x0000A;Japanese Red Cross Nagoya First Hospital</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Takayoshi</FirstName>
				<LastName>Miyazono</LastName>
				<Affiliation>Department of Internal Medicine,&#x0000A;Graduate School of Medicine and Pharmaceutical Sciences,&#x0000A;University of Toyama,&#x0000A;2630 Sugitani,&#x0000A;Toyama 930-0194,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Seiji</FirstName>
				<LastName>Kojima</LastName>
				<Affiliation>Department of Pediatrics,&#x0000A;Nagoya University Graduate School of Medicine</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Tadamichi</FirstName>
				<LastName>Shimizu</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2454</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2454</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25500212</Replaces>
		<ArticleTitle>Elephantiasis nostras verrucosa occurring in voluntary shut-in (&#x0201C;hikikomori&#x0201D;)</ArticleTitle>
		<FirstPage>76</FirstPage>
		<LastPage>77</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Reine</FirstName>
				<LastName>Moriuchi</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Takamasa</FirstName>
				<LastName>Ito</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Kazuhiro</FirstName>
				<LastName>Kikuchi</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yuka</FirstName>
				<LastName>Oshima</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Tomoko</FirstName>
				<LastName>Shikano</LastName>
				<Affiliation>Department of Psychiatry&#x0000A;Sapporo City General Hospital&#x0000A;North 11, West 13, Chuo-ku, Sapporo 060-8604, Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hideki</FirstName>
				<LastName>Takada</LastName>
				<Affiliation>Department of Psychiatry&#x0000A;Sapporo City General Hospital&#x0000A;North 11, West 13, Chuo-ku, Sapporo 060-8604, Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Satoko</FirstName>
				<LastName>Shimizu</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2458</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2458</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25524663</Replaces>
		<ArticleTitle>Unusual location of a blue nevus: development on the lacrimal punctum</ArticleTitle>
		<FirstPage>77</FirstPage>
		<LastPage>78</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Yuko</FirstName>
				<LastName>Ehara</LastName>
				<Affiliation>Division of Dermatology,&#x0000A;Faculty of Medicine,&#x0000A;Department of Medicine of Sensory and Motor Organs,&#x0000A;Tottori University,&#x0000A;86 Nishi-cho, Yonago-shi,&#x0000A;Tottori 683-8503, Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yuichi</FirstName>
				<LastName>Yoshida</LastName>
				<Affiliation>Division of Dermatology,&#x0000A;Faculty of Medicine,&#x0000A;Department of Medicine of Sensory and Motor Organs,&#x0000A;Tottori University,&#x0000A;86 Nishi-cho, Yonago-shi,&#x0000A;Tottori 683-8503, Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Osamu</FirstName>
				<LastName>Yamamoto</LastName>
				<Affiliation>Division of Dermatology,&#x0000A;Faculty of Medicine,&#x0000A;Department of Medicine of Sensory and Motor Organs,&#x0000A;Tottori University,&#x0000A;86 Nishi-cho, Yonago-shi,&#x0000A;Tottori 683-8503, Japan</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2459</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2459</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25513859</Replaces>
		<ArticleTitle>Scalp sarcoidosis mimicking organoid nevus</ArticleTitle>
		<FirstPage>78</FirstPage>
		<LastPage>79</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Toshiyuki</FirstName>
				<LastName>Yamamoto</LastName>
				<Affiliation>Department of Dermatology, Fukushima Medical University, Hikarigaoke 1, Fukushima 960-1295, Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hiroo</FirstName>
				<LastName>Yokozeki</LastName>
				<Affiliation>Tokyo Medical and Dental University, Japan</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2460</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2460</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25513986</Replaces>
		<ArticleTitle>Identification of a recurrent mitochondrial mutation in a Japanese family with palmoplantar keratoderma, nail dystrophy, and deafness</ArticleTitle>
		<FirstPage>79</FirstPage>
		<LastPage>81</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Ryota</FirstName>
				<LastName>Hayashi</LastName>
				<Affiliation>Division of Dermatology,, Laboratory of Genetic Skin Diseases,&#x0000A;Niigata University Graduate School of Medical and Dental Sciences,&#x0000A;1-757 Asahimachi-dori, Chuo-ku,&#x0000A;Niigata 951-8510, Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hiroshi</FirstName>
				<LastName>Fujiwara</LastName>
				<Affiliation>Division of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Michiko</FirstName>
				<LastName>Morishita</LastName>
				<Affiliation>Morishita Dermatology Clinic,&#x0000A;Nagaoka, Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Masaaki</FirstName>
				<LastName>Ito</LastName>
				<Affiliation>Division of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yutaka</FirstName>
				<LastName>Shimomura</LastName>
				<Affiliation>Laboratory of Genetic Skin Diseases,&#x0000A;Niigata University Graduate School of Medical and Dental Sciences,&#x0000A;1-757 Asahimachi-dori, Chuo-ku,&#x0000A;Niigata 951-8510, Japan</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2461</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2461</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25547423</Replaces>
		<ArticleTitle>Blepharoconjunctivitis and an unusual location of metastatic breast carcinoma</ArticleTitle>
		<FirstPage>81</FirstPage>
		<LastPage>82</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Marie</FirstName>
				<LastName>Larquey</LastName>
				<Affiliation>Dermatology department, Nancy University Hospital, H&#x000F4;pitaux de Brabois, rue du Morvan, 54500 Vandoeuvre-l&#x000E8;s-Nancy, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Anne Claire</FirstName>
				<LastName>Bursztejn</LastName>
				<Affiliation>Dermatology department, Nancy University Hospital, H&#x000F4;pitaux de Brabois, rue du Morvan, 54500 Vandoeuvre-l&#x000E8;s-Nancy, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Claire</FirstName>
				<LastName>Poreaux</LastName>
				<Affiliation>Dermatology department, Nancy University Hospital, H&#x000F4;pitaux de Brabois, rue du Morvan, 54500 Vandoeuvre-l&#x000E8;s-Nancy, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Jean-Fran&#x000E7;ois</FirstName>
				<LastName>Cuny</LastName>
				<Affiliation>Dermatology department, Nancy University Hospital, H&#x000F4;pitaux de Brabois, rue du Morvan, 54500 Vandoeuvre-l&#x000E8;s-Nancy, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Jean-Luc</FirstName>
				<LastName>Schmutz</LastName>
				<Affiliation>Dermatology department, Nancy University Hospital, H&#x000F4;pitaux de Brabois, rue du Morvan, 54500 Vandoeuvre-l&#x000E8;s-Nancy, France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2455</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2455</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25514471</Replaces>
		<ArticleTitle>Langerhans cell histiocytosis involving the skin and the thymus</ArticleTitle>
		<FirstPage>82</FirstPage>
		<LastPage>83</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Laurence</FirstName>
				<LastName>de Montjoye</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">H&#x000E9;l&#x000E8;ne</FirstName>
				<LastName>Dano</LastName>
				<Affiliation>Department of Pathology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Liliane</FirstName>
				<LastName>Marot</LastName>
				<Affiliation>Department of Dermatology,, Department of Pathology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Dominique</FirstName>
				<LastName>Tennstedt</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">B&#x000E9;n&#x000E9;dicte</FirstName>
				<LastName>Brichard</LastName>
				<Affiliation>Department of Pediatric Hematology and Oncology,&#x0000A;Cliniques Universitaires Saint-Luc,&#x0000A;Universit&#x000E9; catholique de Louvain,&#x0000A;Avenue Hippocrate 10,&#x0000A;1200 Woluwe-Saint-Lambert,&#x0000A;Belgium</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Pascal</FirstName>
				<LastName>Van Eeckhout</LastName>
				<Affiliation>Department of Pathology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Val&#x000E9;rie</FirstName>
				<LastName>Dekeuleneer</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2465</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2465</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25468734</Replaces>
		<ArticleTitle>Subcutaneous sarcoidal granuloma underlying porokeratosis in a patient with sarcoid-lymphoma syndrome</ArticleTitle>
		<FirstPage>84</FirstPage>
		<LastPage>85</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Toshiyuki</FirstName>
				<LastName>Yamamoto</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Fukushima Medical University,&#x0000A;Hikarigaoka 1,&#x0000A;Fukushima 960-1295,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hiroo</FirstName>
				<LastName>Yokozeki</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Tokyo Medical and Dental University,&#x0000A;Tokyo,&#x0000A;Japan</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2463</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2463</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25514168</Replaces>
		<ArticleTitle>Eruptive nevi and hair depigmentation related to regorafenib</ArticleTitle>
		<FirstPage>85</FirstPage>
		<LastPage>86</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Vincent</FirstName>
				<LastName>Sibaud</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Coline</FirstName>
				<LastName>Munsch</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Laurence</FirstName>
				<LastName>Lamant</LastName>
				<Affiliation>Department of Pathology,&#x0000A;Institut Claudius Regaud - Institut Universitaire du Cancer,&#x0000A;Toulouse Oncopole,&#x0000A;1 rue Ir&#x000E8;ne-Joliot-Curie,&#x0000A;31100 Toulouse,&#x0000A;France</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2462</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2462</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25514351</Replaces>
		<ArticleTitle>Acute generalized exanthematous pustulosis possibly induced by isoniazid in a patient with psoriatic erythroderma</ArticleTitle>
		<FirstPage>86</FirstPage>
		<LastPage>87</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Masataka</FirstName>
				<LastName>Satoh</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Fukushima Medical University School of Medicine,&#x0000A;1-Hikarigaoka,&#x0000A;Fukushima,&#x0000A;960-1295,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yasunobu</FirstName>
				<LastName>Kato</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Fukushima Medical University School of Medicine,&#x0000A;1-Hikarigaoka,&#x0000A;Fukushima,&#x0000A;960-1295,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Toshiyuki</FirstName>
				<LastName>Yamamoto</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Fukushima Medical University School of Medicine,&#x0000A;1-Hikarigaoka,&#x0000A;Fukushima,&#x0000A;960-1295,&#x0000A;Japan</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2464</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2464</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25547780</Replaces>
		<ArticleTitle>Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities</ArticleTitle>
		<FirstPage>87</FirstPage>
		<LastPage>89</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Fumi</FirstName>
				<LastName>Miyagawa</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Nara Medical University School of Medicine,&#x0000A;840 Shijo,&#x0000A;Kashihara,&#x0000A;Nara 634-8522,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Ayako</FirstName>
				<LastName>Hasegawa</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Nara Medical University School of Medicine,&#x0000A;840 Shijo,&#x0000A;Kashihara,&#x0000A;Nara 634-8522,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Kyoko</FirstName>
				<LastName>Imoto</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Nara Medical University School of Medicine,&#x0000A;840 Shijo,&#x0000A;Kashihara,&#x0000A;Nara 634-8522,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Kohei</FirstName>
				<LastName>Ogawa</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Nara Medical University School of Medicine,&#x0000A;840 Shijo,&#x0000A;Kashihara,&#x0000A;Nara 634-8522,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Nobuhiko</FirstName>
				<LastName>Kobayashi</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Nara Medical University School of Medicine,&#x0000A;840 Shijo,&#x0000A;Kashihara,&#x0000A;Nara 634-8522,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Kayoko</FirstName>
				<LastName>Ito</LastName>
				<Affiliation>Department of Environmental Immuno-Dermatology,&#x0000A;Yokohama City University Graduate School of Medicine,&#x0000A;Yokohama,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hiroyuki</FirstName>
				<LastName>Fujita</LastName>
				<Affiliation>Department of Environmental Immuno-Dermatology,&#x0000A;Yokohama City University Graduate School of Medicine,&#x0000A;Yokohama,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Michiko</FirstName>
				<LastName>Aihara</LastName>
				<Affiliation>Department of Environmental Immuno-Dermatology,&#x0000A;Yokohama City University Graduate School of Medicine,&#x0000A;Yokohama,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hideaki</FirstName>
				<LastName>Watanabe</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Showa University School of Medicine,&#x0000A;Tokyo,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hirohiko</FirstName>
				<LastName>Sueki</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Showa University School of Medicine,&#x0000A;Tokyo,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Mikiko</FirstName>
				<LastName>Tohyama</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Ehime University Graduate School of Medicine,&#x0000A;Matsuyama,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hideo</FirstName>
				<LastName>Asada</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Nara Medical University School of Medicine,&#x0000A;840 Shijo,&#x0000A;Kashihara,&#x0000A;Nara 634-8522,&#x0000A;Japan</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2477</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2477</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25500562</Replaces>
		<ArticleTitle>Extramammary Paget&#x00027;s disease occurring in the context of Cowden syndrome: true association or mere coincidence?</ArticleTitle>
		<FirstPage>89</FirstPage>
		<LastPage>91</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Kotaro</FirstName>
				<LastName>Matsui</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Teruhiko</FirstName>
				<LastName>Makino</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Megumi</FirstName>
				<LastName>Mizawa</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Takeru</FirstName>
				<LastName>Hamashima</LastName>
				<Affiliation>Department of Pathology,&#x0000A;Graduate School of Medicine,&#x0000A;University of Toyama,&#x0000A;2630 Sugitani,&#x0000A;Toyama 930-0194,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Hironori</FirstName>
				<LastName>Hanakawa</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Shinseikai Toyama Hospital,&#x0000A;Imizu,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Naohito</FirstName>
				<LastName>Hatta</LastName>
				<Affiliation>Department of Dermatology,&#x0000A;Toyama Prefectural Central Hospital,&#x0000A;Toyama,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Masakiyo</FirstName>
				<LastName>Sasahara</LastName>
				<Affiliation>Department of Pathology,&#x0000A;Graduate School of Medicine,&#x0000A;University of Toyama,&#x0000A;2630 Sugitani,&#x0000A;Toyama 930-0194,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Tadamichi</FirstName>
				<LastName>Shimizu</LastName>
				<Affiliation>Department of Dermatology</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2475</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2475</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25464929</Replaces>
		<ArticleTitle>Giant pedunculated pilomatrix carcinoma on the upper limb: A rare clinical appearance</ArticleTitle>
		<FirstPage>91</FirstPage>
		<LastPage>92</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Sayuri</FirstName>
				<LastName>Sato</LastName>
				<Affiliation>Department of Skin Oncology/Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yasuhiro</FirstName>
				<LastName>Nakamura</LastName>
				<Affiliation>Department of Skin Oncology/Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Michio</FirstName>
				<LastName>Shimizu</LastName>
				<Affiliation>Department of Pathology,&#x0000A;Saitama Medical University International Medical Center,&#x0000A;1397-1 Yamane, Hidaka, Saitama,&#x0000A;350-1298 Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Katsuhiro</FirstName>
				<LastName>Yamada</LastName>
				<Affiliation>Department of Skin Oncology/Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Yukiko</FirstName>
				<LastName>Teramoto</LastName>
				<Affiliation>Department of Skin Oncology/Dermatology</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Naoya</FirstName>
				<LastName>Yamazaki</LastName>
				<Affiliation>Department of Dermatologic Oncology,&#x0000A;National Cancer Center Hospital,&#x0000A;Tokyo,&#x0000A;Japan</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Akifumi</FirstName>
				<LastName>Yamamoto</LastName>
				<Affiliation>Department of Skin Oncology/Dermatology</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2014.2476</ArticleId><ArticleId IdType="doi">10.1684/ejd.2014.2476</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25786851</Replaces>
		<ArticleTitle>Residents&#x02019;corner February 2015. Editorial: 2015 Renewal of the Resident Board</ArticleTitle>
		<FirstPage>93</FirstPage>
		<LastPage>93</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Alejandro</FirstName>
				<LastName>Martin-Gorgojo</LastName>
				<Affiliation>Dermatology Department. General University Hospital &#x000AB;Gregorio Mara&#x000F1;on&#x000BB;. C/ Doctor Esquerdo 46, 28007 Madrid, Spain. Dermatology Department. Clinica Dermatologica Internacional and Clinica Ruber. Madrid, Spain</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2015.2538</ArticleId><ArticleId IdType="doi">10.1684/ejd.2015.2538</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25787022</Replaces>
		<ArticleTitle>Residents&#x02019;corner February 2015. Editorial: What&#x00027;s new this month?</ArticleTitle>
		<FirstPage>94</FirstPage>
		<LastPage>95</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Axel-Patrice</FirstName>
				<LastName>Villani</LastName>
				<Affiliation>Dermatology department, h&#x000F4;pital Edouard Herriot. 5 place d&#x02019;Arsonval, 69003 Lyon, France</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Valeria</FirstName>
				<LastName>Behle</LastName>
				<Affiliation>Department of Dermatology, Venereology and Allergology, University Hospital Wuerzburg, Josef-Schneider-Str. 2, 97080 Wuerzburg, Germany</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Joana</FirstName>
				<LastName>cabete</LastName>
				<Affiliation>Dermatology Department. Hospital de Santo Ant&#x000F3;nio dos Capuchos - Centro Hospitalar de Lisboa Central. Alameda Santo Ant&#x000F3;nio dos Capuchos 1169-050, Lisbon, Portugal</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Alana</FirstName>
				<LastName>Durack</LastName>
				<Affiliation>Dermatology department, Box 46, Addenbrooke&#x00027;s Hospital, Hills road, Cambridge, CB2 0QQ, UK</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Fran&#x000E7;ois</FirstName>
				<LastName>Kuonen</LastName>
				<Affiliation>Department of Dermatology and Venereology, H&#x000F4;pital de Beaumont, Lausanne University Hospital Center, Av. de Beaumont 29, CH-1011 Lausanne, Switzerland</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Alejandro</FirstName>
				<LastName>Martin-Gorgojo</LastName>
				<Affiliation>Dermatology Department. General University Hospital Gregorio Mara&#x000F1;on. C/ Doctor Esquerdo 46, 28007 Madrid, Spain. Dermatology Department. Clinica Dermatologica Internacional and Clinica Ruber. Madrid, Spain</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2015.2539</ArticleId><ArticleId IdType="doi">10.1684/ejd.2015.2539</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25787161</Replaces>
		<ArticleTitle>Residents&#x02019;corner February 2015. sQUIZ your knowledge!</ArticleTitle>
		<FirstPage>95</FirstPage>
		<LastPage>96</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Jin</FirstName>
				<LastName>Wei</LastName>
				<Affiliation>Department of Dermatology, Peking University People&#x00027;s Hospital, Beijing, China</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Jianzhong</FirstName>
				<LastName>Zhang</LastName>
				<Affiliation>Department of Dermatology, Peking University People&#x00027;s Hospital, Beijing, China</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2015.2540</ArticleId><ArticleId IdType="doi">10.1684/ejd.2015.2540</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25787317</Replaces>
		<ArticleTitle>Residents&#x02019;corner February 2015. DeRmpath &#38; Clinic &#x02013; Leukocytoclastic vasculitis</ArticleTitle>
		<FirstPage>96</FirstPage>
		<LastPage>97</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Justyn M.</FirstName>
				<LastName>Thomas</LastName>
				<Affiliation>Dermatology Department, Addenbrooke&#x00027;s Hospital, Hills Road, Cambridge, CB2 0QQ</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Alana</FirstName>
				<LastName>Durack</LastName>
				<Affiliation>Dermatology Department, Addenbrooke&#x00027;s Hospital, Hills Road, Cambridge, CB2 0QQ</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">George</FirstName>
				<LastName>Meligonis</LastName>
				<Affiliation>Dermatology Department, Addenbrooke&#x00027;s Hospital, Hills Road, Cambridge, CB2 0QQ</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2015.2541</ArticleId><ArticleId IdType="doi">10.1684/ejd.2015.2541</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25787722</Replaces>
		<ArticleTitle>Residents&#x02019;corner February 2015. Clues in DeRmoscopy: Dermoscopy of amelanotic cutaneous melanoma metastases</ArticleTitle>
		<FirstPage>97</FirstPage>
		<LastPage>98</LastPage>
		<AuthorList>
			<Author>
				<FirstName EmptyYN="N">Fran&#x000E7;ois</FirstName>
				<LastName>Kuonen</LastName>
				<Affiliation>Department of Dermatology and Venereology, H&#x000F4;pital de Beaumont, Lausanne University Hospital Center, CH-1011 Lausanne, Switzerland</Affiliation>
			</Author>
			<Author>
				<FirstName EmptyYN="N">Olivier</FirstName>
				<LastName>Gaide</LastName>
				<Affiliation>Department of Dermatology and Venereology, H&#x000F4;pital de Beaumont, Lausanne University Hospital Center, CH-1011 Lausanne, Switzerland</Affiliation>
			</Author>
		</AuthorList>
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2015.2542</ArticleId><ArticleId IdType="doi">10.1684/ejd.2015.2542</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>
	<Article>
		<Journal>
			<PublisherName>John Libbey Eurotext</PublisherName>
			<JournalTitle>Eur J Dermatol</JournalTitle>
			<Issn>1167-1122</Issn>
			<Volume>25</Volume>
			<Issue>1</Issue>
			<PubDate PubStatus="ppublish">
				<Year>2015</Year>
				<Month>02</Month>
				<Day>01</Day>
			</PubDate>
		</Journal>
		<Replaces IdType="pubmed">25787899</Replaces>
		<ArticleTitle>Announcements: DeRmaCalendar 25-1</ArticleTitle>
		<FirstPage>99</FirstPage>
		<LastPage>99</LastPage>
		<AuthorList />
		<PublicationType></PublicationType>
		<ArticleIdList><ArticleId IdType="pii">ejd.2015.2543</ArticleId><ArticleId IdType="doi">10.1684/ejd.2015.2543</ArticleId></ArticleIdList>
		<History></History>
		<Abstract></Abstract>
	</Article>

</ArticleSet>